MedPath

Evaluation of conjunctival hyperemia induced by Glanatec ophthalmic solution 0.4%

Not Applicable
Conditions
Primary Open-Angle Glaucoma or Ocular Hypertension
Registration Number
JPRN-UMIN000019565
Lead Sponsor
Kochi medical school hospital,ophthalmology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients having hypersensitivity against ripasujiru hydrochloride hydrate, Anhydrous dihydrogen phosphate sodium, Glycerine, Sodium hydroxide, Dark benzalconium chloride liquid 50. 2)Less than -12 dB of the MD value 3)Regarding pregnant women, Women whose terms are closed to and Lactating women, benefit is superior to dangerousness. 4)Secondary glaucoma, Exfoliation glaucoma,Angle closure glaucoma 5)Refract value: Less than-9.0D,More than +9.0D 6)Patients whose intra ocular pressure can not be measured by iCare Tonometer 7)Patients with traumatic injury. 8)Patients with ocular inflammation of anterior segment. 9)Patients who can not be applied for photo slit. 10)Patients having a history of the operation during the past 6 months. 11)Users of contact lenses 12)Patients who are decided not be suitable for this trial by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath